Literature DB >> 11788474

Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population.

Furcy Paultre1, Catherine H Tuck, Bernadette Boden-Albala, Douglas E Kargman, Elizabeth Todd, Jeffrey Jones, Myunghee C Paik, Ralph L Sacco, Lars Berglund.   

Abstract

Lipoprotein(a) [Lp(a)] is a novel risk factor for atherosclerosis, whose role in multiracial populations has been debated. We recently demonstrated a significant association of elevated levels of Lp(a) carried in particles containing small apolipoprotein(a) [apo(a)] isoforms with coronary artery disease in African American and white men. To extend these findings, we investigated the associations between Lp(a) levels, apo(a) size, and maximum internal carotid artery plaque thickness (MPT) in a randomly selected elderly multiethnic population (173 men and 253 women, consisting of 135 African Americans, 146 Hispanics, and 145 whites; mean age 70.5+/-11.4 years). Lp(a) levels were not associated with MPT. Among white men, MPT was associated with a small apo(a) isoform size (P=0.03) as well as with the amount of Lp(a) carrying the small apo(a) size (P=0.04), and the latter showed a borderline association in African American men (P=0.07). Among white women, but not in Hispanic or African American women, MPT was associated with the amount of Lp(a) carrying a small apo(a) isoform size (P<0.01). For all patients, the amount of Lp(a) carrying the small apo(a) size was associated with carotid atherosclerosis when there was control for age, sex, ethnicity, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triglycerides, diabetes mellitus, hypertension, waist-to-hip ratio, and current smoking status (P=0.03). This association was significant for all men (P=0.03) and for white women (P=0.007). The results suggest that molecular properties of apo(a) are important in determining the atherogenicity of Lp(a).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788474      PMCID: PMC2812916          DOI: 10.1161/hq0102.101097

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  37 in total

1.  Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women.

Authors:  C H Tuck; S Holleran; L Berglund
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-09       Impact factor: 8.311

2.  Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients.

Authors:  D Baldassarre; E Tremoli; G Franceschini; S Michelagnoli; C R Sirtori
Journal:  Stroke       Date:  1996-06       Impact factor: 7.914

3.  The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans.

Authors:  V Mooser; D Scheer; S M Marcovina; J Wang; R Guerra; J Cohen; H H Hobbs
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

4.  Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans.

Authors:  S M Marcovina; J J Albers; E Wijsman; Z Zhang; N H Chapman; H Kennedy
Journal:  J Lipid Res       Date:  1996-12       Impact factor: 5.922

5.  Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.

Authors:  C Gazzaruso; A Garzaniti; P Buscaglia; G Bonetti; C Falcone; P Fratino; G Finardi; D Geroldi
Journal:  J Am Coll Cardiol       Date:  1999-01       Impact factor: 24.094

Review 6.  Lipoprotein Lp(a) excess and coronary heart disease.

Authors:  J H Stein; R S Rosenson
Journal:  Arch Intern Med       Date:  1997-06-09

7.  Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study.

Authors:  R L Sacco; J K Roberts; B Boden-Albala; Q Gu; I F Lin; D E Kargman; L Berglund; W A Hauser; S Shea; M C Paik
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

8.  Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study.

Authors:  A G Bostom; L A Cupples; J L Jenner; J M Ordovas; L J Seman; P W Wilson; E J Schaefer; W P Castelli
Journal:  JAMA       Date:  1996-08-21       Impact factor: 56.272

9.  A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants.

Authors:  S H Wild; S P Fortmann; S M Marcovina
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-02       Impact factor: 8.311

10.  Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.

Authors:  F Kronenberg; M F Kronenberg; S Kiechl; E Trenkwalder; P Santer; F Oberhollenzer; G Egger; G Utermann; J Willeit
Journal:  Circulation       Date:  1999-09-14       Impact factor: 29.690

View more
  19 in total

Review 1.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

2.  Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox.

Authors:  Joshua Z Willey; Carlos J Rodriguez; Yeseon Park Moon; Myunghee C Paik; Marco R Di Tullio; Shunichi Homma; Ralph L Sacco; Mitchell S V Elkind
Journal:  Ann Epidemiol       Date:  2012-03-15       Impact factor: 3.797

3.  Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan Study.

Authors:  Joshua Z Willey; Carlos J Rodriguez; Richard F Carlino; Yeseon Park Moon; Myunghee C Paik; Bernadette Boden-Albala; Ralph L Sacco; Marco R DiTullio; Shunichi Homma; Mitchell S V Elkind
Journal:  Am Heart J       Date:  2011-05       Impact factor: 4.749

Review 4.  Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Tina Tran; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2011-07-12       Impact factor: 1.894

Review 5.  Lipoprotein(a) and atherosclerosis: new perspectives on the mechanism of action of an enigmatic lipoprotein.

Authors:  Marlys L Koschinsky
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

6.  Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS).

Authors:  Joshua Z Willey; Qiang Xu; Bernadette Boden-Albala; Myunghee C Paik; Yeseon Park Moon; Ralph L Sacco; Mitchell S V Elkind
Journal:  Arch Neurol       Date:  2009-11

Review 7.  Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.

Authors:  Angelo M Scanu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

8.  Lipids and carotid plaque in the Northern Manhattan Study (NOMAS).

Authors:  Hannah Gardener; David Della Morte; Mitchell S V Elkind; Ralph L Sacco; Tatjana Rundek
Journal:  BMC Cardiovasc Disord       Date:  2009-12-22       Impact factor: 2.298

9.  Multiple genetic determinants of plasma lipid levels in Caribbean Hispanics.

Authors:  Yi-Chu Liao; Hsiu-Fen Lin; Tanja Rundek; Rong Cheng; Edward Hsi; Ralph L Sacco; Suh-Hang Hank Juo
Journal:  Clin Biochem       Date:  2007-11-29       Impact factor: 3.281

10.  Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study.

Authors:  Joshua Z Willey; Hannah Gardener; Yeseon P Moon; Mitsuhiro Yoshita; Charles DeCarli; Ying Kuen Cheung; Ralph L Sacco; Mitchell S V Elkind; Clinton B Wright
Journal:  Cerebrovasc Dis       Date:  2014-07-12       Impact factor: 2.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.